Loading insider details...
Beta
Latest Form 4 (Sep 14, 2026): Purchase of 12,500,000 HEPA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase | 12,500,000 | n/a |
| Aug 21, 2026 | Hepion Pharmaceuticals, Inc. (HEPA) | Grant/Award | 1,345,500 | n/a |
| Aug 13, 2026 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase | 8,000,000 | $400.0K |
| Apr 27, 2026 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase | 5,000,000 | $200.0K |
| Nov 6, 2025 | Tharimmune, Inc. (THAR) | Grant/Award | 90,000 | n/a |